Author name: cultivate(MD)

shoulder innovations genesis news

Shoulder Innovations Announces Exclusive License Agreement for Genesis Software Innovations PreView Shoulder™ Software

Press Release /

HOLLAND, Mich., May 10th, 2021 – Shoulder Innovations (SI), an emerging leader in the development of shoulder replacement systems, announced today that it has signed an exclusive license agreement for Genesis Software Innovation‘s “GSI“ PreView Shoulder™ Arthroplasty Planning Software, which recently achieved FDA 510(k) clearance. This clearance is the first musculoskeletal solution under the FDA’s […]

Shoulder Innovations Announces Exclusive License Agreement for Genesis Software Innovations PreView Shoulder™ Software Read More »

preview shoulder software

Genesis Software Innovations Announces FDA 510(K) Clearance for Preview™ 3D Shoulder Arthroplasty Planning Software

Press Release /

GRAND RAPIDS, Mich., May 5th, 2021—Genesis Software Innovations “GSI,” a company that has created an innovative foundational platform solution in the orthopedic space, announced today that they have received FDA clearance for their Preview™ 3D Shoulder Arthroplasty Planning Software. The Preview™ Shoulder Software is a breakthrough tool for orthopedic surgeons to develop pre-operative shoulder plans

Genesis Software Innovations Announces FDA 510(K) Clearance for Preview™ 3D Shoulder Arthroplasty Planning Software Read More »

cultivate post

Medical Ingenuities Receives FDA 510(k) Clearance for PH Band

Press Release /

Novel radial artery occlusion device removes the guesswork from achieving Patent Hemostasis Holland, Mich. – December 9th, 2020 – Genesis Innovation Group’s cultivate(MD) Capital Fund II LP, a fund focused on investments into early stage healthcare companies with innovative technologies, announces that one of their portfolio companies, Wheaton, IL-based Medical Ingenuities, a medical device company

Medical Ingenuities Receives FDA 510(k) Clearance for PH Band Read More »

Embody's logo capturing the mission of repair, regenerate, and restore.

Embody, Inc. Announces FDA 510(k) Clearance of TAPESTRY® Biointegrative Implant for Tendon and Ligament Repair

Press Release /

Holland, Mich. – October 29, 2020 – Genesis Innovation Group’s cultivate(MD) Seed Fund, a fund focused on investments into early-stage healthcare companies with innovative technologies, announces that one of their portfolio companies, Norfolk, VA based Embody, Inc. has received FDA 510(k) clearance for their TAPESTRY® Biointegrative Implant for Tendon and Ligament Repair.

Embody, Inc. Announces FDA 510(k) Clearance of TAPESTRY® Biointegrative Implant for Tendon and Ligament Repair Read More »

Start typing and press enter to search